Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Morlock currently holds 220,766 shares of BioPharmX Corp (BPMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Morlock has been a net buyer of BPMX stock. They have purchased $244.2K and sold $206.9K worth of shares.
Stephen Morlock's most recent insider trade was on Oct 22, 2018, when they sold 251,071 shares at $0.18 per share.
Stephen Morlock serves as Executive at BioPharmX Corp (BPMX). They have executed 21 insider transactions totaling $451.1K over their tenure at the company.
Stephen Morlock holds the position of Executive at BioPharmX Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Stephen Morlock has shown a buying trading pattern, with $244.2K in total purchases and $206.9K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Stephen Morlock was on Nov 28, 2016, when they purchased $150.0K worth of BPMX shares. This transaction involved 428,571 shares at $0.35 per share.
Stephen Morlock currently owns 220,766 shares of BioPharmX Corp (BPMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Morlock's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Morlock has 21 Form 4 filings on record as an insider at BioPharmX Corp.
Set alerts for Stephen Morlock and 40,000+ other insiders.